Physician profile
Shelby Bennett
NPI 1538473491
$8,522.46
in general payments reported to CMS, 2019-2025
30 companies · $3,623 in 2025
The $3,623 reported for 2025 was more than what 93% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $393 · 2021: $359 · 2022: $415 · 2023: $3,089 · 2024: $172 · 2025: $3,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,863 · Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,862.65 |
| Food and Beverage | $2,020.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,853.58 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Ge Healthcare | $1,941.62 | 2023-2024 | |
| Merit Medical Systems INC | $1,489.73 | 2025 | Embosphere Microspheres, Swiftninja Sterble Cor Micro |
| Medtronic, INC. | $1,099.79 | 2023 | Endurant Iis |
| Biocompatibles, INC. | $190.31 | 2019 | |
| Cardiovascular Systems INC. | $173.73 | 2019-2022 | |
| Cook Medical LLC | $161.99 | 2019 | |
| Bard Peripheral Vascular, INC. | $138.64 | 2020-2021 | |
| Amgen INC. | $61.25 | 2022 | |
| United Imaging Healthcare North America LLC | $57.72 | 2024 | Ct, Mr, Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $42.57 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $33.94 | 2021-2023 | Verquvo |
| Jazz Pharmaceuticals INC. | $24.19 | 2022 | |
| Daiichi Sankyo INC. | $22.98 | 2022 | |
| Angiodynamics, INC. | $21.14 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $18.11 | 2022 | |
| Chiesi USA, INC. | $16.61 | 2022 | |
| Varian Medical Systems, INC. | $16.32 | 2020 | |
| Seagen INC. | $16.04 | 2023 | Adcetris |
| Novartis Pharmaceuticals Corporation | $14.55 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.18 | 2019 | |
| Medtronic Vascular, INC. | $13.92 | 2020 | |
| Genzyme Corporation | $13.79 | 2019 | |
| Covidien LP | $13.18 | 2020 | |
| Endocare, INC. | $12.98 | 2019 | |
| Eusa Pharma (US) LLC | $12.62 | 2021 | |
| Inari Medical, INC. | $12.53 | 2022 | |
| Array Biopharma INC | $12.08 | 2019 | |
| Janssen Biotech, INC. | $11.44 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelby Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.